Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Double - Blind, Randomized, single centered study. The purpose of this study is to assess the
feasibility of minocycline vs. placebo, added to atypical antipsychotic medications, for
positive symptoms in adults suffering from schizophrenia.